Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ab initio structure determination of anhydrous sodium alendronate from laboratory powder X-ray diffraction data.

Journal of pharmaceutical sciences·2008
Same author

A remarkable accelerating effect of Ag-salt on intramolecular cyclization of o-(1-alkynyl)benzenesulfonamides.

The Journal of organic chemistry·2007
Same author

Tandem C-C coupling--intramolecular acetylenic Schmidt reaction under Pd/C-Cu catalysis.

Chemical communications (Cambridge, England)·2007
Same author

(S)-3-(Ammoniomethyl)-5-methylhexanoate (pregabalin).

Acta crystallographica. Section C, Crystal structure communications·2007
Same author

Molecular dynamics study of the interactions of ice inhibitors on the ice {001} surface.

Langmuir : the ACS journal of surfaces and colloids·2005

Related Experiment Video

Updated: Jul 5, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
12:21

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Published on: November 27, 2016

Desvenlafaxine succinate monohydrate.

Nalivela Venu1, Bukkapattanam R Sreekanth, Thaimattam Ram

  • 1Centre for Excellence in Polymorphism and Particle Engineering, Dr Reddy's Laboratories Ltd, IPDO Innovation Plaza, Bachupally, Hyderabad, India.

Acta Crystallographica. Section C, Crystal Structure Communications
|May 3, 2008
PubMed
Summary
This summary is machine-generated.

This study details the crystal structure of a new antidepressant, O-desmethylvenlafaxine (desvenlafaxine) succinate salt. Its unique hydrogen-bonding network explains its high thermal stability and solubility.

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)
08:33

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)

Published on: June 28, 2011

Related Experiment Videos

Last Updated: Jul 5, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
12:21

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram

Published on: November 27, 2016

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)
08:33

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)

Published on: June 28, 2011

Area of Science:

  • Crystallography
  • Materials Science
  • Pharmacology

Background:

  • O-desmethylvenlafaxine (desvenlafaxine) is a novel antidepressant drug.
  • The compound is formulated as a succinate salt, with four known polymorphs.
  • Understanding the crystal structure is crucial for drug development.

Purpose of the Study:

  • To characterize a specific polymorph of the desvenlafaxine succinate salt.
  • To elucidate the role of hydrogen bonding in the compound's structural properties.
  • To correlate crystal structure with thermal stability and solubility.

Main Methods:

  • Single-crystal X-ray diffraction analysis.
  • Analysis of hydrogen-bonding interactions and network formation.
  • Thermal analysis (desolvation and melting point determination).

Main Results:

  • The crystal structure reveals a rare anti conformation of the succinate anion.
  • Distinct hydrogen-bonded networks are formed by cations (desvenlafaxine) and anions (succinate) with water molecules.
  • A strong, interconnected hydrogen-bonding network leads to simultaneous desolvation and melting at approximately 402 K.

Conclusions:

  • The crystal structure provides molecular-level insights into the thermal stability and solubility of desvenlafaxine succinate.
  • The identified hydrogen-bonding patterns are key to the compound's physical properties.
  • This structural understanding aids in the development and formulation of this new antidepressant.